<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <funding-statement>NRF is funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal Society Grant 204311/Z/16/Z). JL was funded by the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007–2013) / ERC grant agreement no. 268904 – DIVERSITY. The research leading to these results has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 725422-ReservoirDOCS). MAS and PL acknowledge funding from the Wellcome Trust Collaborative Award, 206298/Z/17/Z and the European Research Council award ReservoirDOCS. MAS acknowledges funding from the National Science Foundation through grant DMS 1264153 and the National Institutes of Health through grants AI107034 and AI135995. ACPP was supported by European Funds through grant ‘Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe (BEST HOPE) (project funded through HIVERA: Harmonizing Integrating Vitalizing European Research on HIV/Aids, grant 249697). AJT is supported by funding from the Bill &amp; Melinda Gates Foundation (OPP1182408, OPP1106427, 1032350, OPP1134076), the Clinton Health Access Initiative, National Institutes of Health, a Wellcome Trust Sustaining Health Grant (106866/Z/15/Z), and funds from DFID and the Wellcome Trust (204613/Z/16/Z). TFRW received funding from NOW-WOTRO and the Netherlands Regional AIDS Program in Southern Africa. NN received funding from Abbott (ISR#212620). GB acknowledges support from the Interne Fondsen KU Leuven / Internal Funds KU Leuven under grant agreement C14/18/094, and the computational resources and services provided by the VSC (Flemish Supercomputer Center), funded by the Research Foundation - Flanders (FWO) and the Flemish Government - department EWI. OGP received funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007 – 2013)/ERC grant agreement no. 614725 - PATHPHYLODYN. PL acknowledges support by the Special Research Fund, KU Leuven (Bijzonder Onderzoeksfonds, KU Leuven, OT/14/115), and the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen, G066215N, G0D5117N and G0B9317N). SD was supported by the Wiener-Anspach Foundation and the Fonds Wetenschappelijk Onderzoek (FWO, Belgium), and is currently funded by the Fonds National de la Recherche Scientifique (FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
